GSK | GenomeWeb


It's Electric

GlaxoSmithKline and Verily Life Sciences form Galvani Bioelectronics.

Drug developers and genetic testing firms are contemplating how best to share variant classification data while protecting their commercial interests.

Five people have been indicted for stealing trade secrets from GlaxoSmithKline, the Wall Street Journal reports.

Therapies aimed at drug targets that have been linked genetically to disease fare better through the drug development pipeline, researchers from GSK and elsewhere found.

The institute will develop new technologies and approaches to decode how genes are controlled and how a cell's "operating system" functions. 

NEW YORK (GenomeWeb) – A team led by researchers at Cellzome, a part of GlaxoSmithKline's R&D division, has developed a thermal profiling-based method for identifying protein drug targets and measuring protein-drug binding.

NEW YORK (GenomeWeb) – GE Healthcare today announced a deal between its affiliate Clarient Diagnostic Services and GlaxoSmithKline to create a network of clinical laboratories to identify genetic mutations associated with different tumor types.

NEW YORK (GenomeWeb) – Thermo Fisher Scientific, GlaxoSmithKline, and Pfizer are collaborating to develop a universal next-generation sequencing-based oncology test for solid tumors that will serve as a companion diagnostic for several drug programs, Thermo said today.


In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.